Skip to main content
SpringerLink
Log in

Haemostasis and Thrombosis: Observations on Atrial Fibrillation and Platelets

  • Reference work entry
  • First Online:
PanVascular Medicine

  • 200 Accesses

Abstract

Atrial fibrillation (AF) is a growing “epidemic” and carries an important morbidity and mortality due to associated thromboembolic complications. Thrombogenesis in AF has been studied elaborately but still remains complex.

Virchow’s triad postulated 150 years ago still seems to hold good as the basis of thrombogenesis requiring abnormality in blood flow, vessel wall, and blood constituents. Among blood constituents abnormalities in hemostasis, platelets, and the endothelium have been identified leading to hypercoagulable state with varying contributions. While antiplatelet therapy is still widely used in AF, it only seems to offer marginal benefit in people with associated vascular risk factors and debatable benefit in people without associated risk factors.

This chapter provides an overview of the role of platelets in the pathophysiology of thrombogenesis in AF and antiplatelet therapy in AF.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 649.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 549.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Abbreviations

Antiplatelet therapy:

Drugs used to inhibit platelet function/action eg aspirin.

Atrial fibrillation:

The commonest cardiac rhythm disorder, characterised by irregular and chaotic atrial electrical activity and irregular rate and rhythm.

Platelet activation:

A situation with abnormal platelet activity leading to a propensity to clot.

Platelets:

Small cells within the blood that are involved in clotting mechanisms.

References

  • Akar JG, Jeske W, Wilber DJ (2008) Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction. J Am Coll Cardiol 51:1790–1793

    Article  CAS  PubMed  Google Scholar 

  • Antithrombotic Therapy in Atrial Fibrillation Study Group (2006) The randomized study of efficiency and safety of antithrombotic therapy in nonvalvular atrial fibrillation: warfarin compared with aspirin. Zhonghua Xin Xue Guan Bing Za Zhi 34:295–298

    Google Scholar 

  • Baumgartner HR (1973) The role of blood flow in platelet adhesion fibrin deposition and formation of mural thrombi. Microvasc Res 5:167–179

    Article  CAS  PubMed  Google Scholar 

  • Beppu S, Park YD, Sakakibara H, Nagata S, Numura Y (1984) Clinical features of intracardiac thrombosis based on echocardiographic observation. Jpn Circ J 48:75–82

    Article  CAS  PubMed  Google Scholar 

  • Blann AD, Lip GY, Beevers DG, McCollum CN (1997) Soluble P-Selectin in atherosclerosis: a comparison with endothelial cell and platelet markers. Thromb Haemost 77:1077–1080

    CAS  PubMed  Google Scholar 

  • Bover R, Pérez-Gómez F, Maluenda MP, Asenjo S, Pérez-Saldaña R, Igea A, Suárez M, Coleto D, Fernández C (2009) Long-term follow-up of atrial fibrillation patients in the NASPEAF study. Prospective evaluation of different antiplatelet treatments. Rev Esp Cardiol 62:992–1000

    Article  PubMed  Google Scholar 

  • Boyaci A, Topaloglu S, Yilmaz S, Yanik O, Ozdemir O, Demir AD, Aras D, Kisacik H, Korkmaz S (2004) Regional left atrial coagulation and fibrinolytic activities in patients with mitral stenosis. Jpn Heart J 45:779–788

    Article  PubMed  Google Scholar 

  • Cahill MR, Newland AC (1993) Platelet activation in coronary artery disease. Br J Biomed Sci 50:221–234

    CAS  PubMed  Google Scholar 

  • Cai H, Li Z, Goette A, Mera F, Honeycutt C, Feterik K, Wilcox JN, Dudley SC Jr, Harrison DG, Langberg JJ (2002) Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation 106:2854–2858

    Article  CAS  PubMed  Google Scholar 

  • Chen YC, Wu KK (1980) A comparison of methods for the study of platelet hyperfunction in thromboembolic disorders. Br J Haematol 46:263–268

    Article  CAS  PubMed  Google Scholar 

  • Chen MC, Wu CJ, Yip HK, Chang HW, Fang CY, Yu TH, Fu M (2003) Left atrial platelet activity with rheumatic mitral stenosis: correlation study of severity and platelet P-selectin expression by flow cytometry. Chest 124:1663–1669

    Article  PubMed  Google Scholar 

  • Choudhury A, Chung I, Blann AD, Lip GYH (2007a) Platelet surface CD62p and CD 63, mean platelet volume and soluble P-selectin as indices of platelet function in atrial fibrillation. J Am Coll Cardiol 49:1957–1964

    Article  CAS  PubMed  Google Scholar 

  • Choudhury A, Chung I, Blann AD, Lip GY (2007b) Elevated platelet microparticle levels in nonvalvular atrial fibrillation: relationship to p-selectin and antithrombotic therapy. Chest 131:809–815

    Article  CAS  PubMed  Google Scholar 

  • Chung NA, Belgore F, Li-Saw-Hee FL, Conway DS, Blann AD, Lip GY (2002) Is the hypercoagulable state in atrial fibrillation mediated by vascular endothelial growth factor? Stroke 33:2187–2191

    Article  CAS  PubMed  Google Scholar 

  • Collins CE, Cahill MR, Newland AC, Rampton DS (1994) Platelets circulate in an activated state in inflammatory bowel disease. Gastroenterology 106:840–845

    Article  CAS  PubMed  Google Scholar 

  • Connolly SJ, Pogue J, Hart RG, Hohnloser SH, Pfeffer M, Chrolavicius S, Yusuf S (2009) Effect of clopidogrel added to aspirin in patients with atrial fibrillation. ACTIVE Investigators. N Engl J Med 360:2066–2078

    Article  PubMed  Google Scholar 

  • Connolly S, Eikelboom J, Flaker G, Kaatz S, Avezum A, Piegas L, Hermosillo A, Hohnlose S, Golitsyn S,Yusuf S et al (2010) AVERROES: apixaban versus acetyl salicyclic acid to prevent strokes. Presented at European Society of Cardiology, Stockholm, 31 Aug 2010

    Google Scholar 

  • Conway DSG, Pearce LA, Chin BSP, Hart RG, Lip GYH (2002) Plasma von Willebrand factor and soluble; P-selectin as indices of endothelial damage and platelet activation in 1321 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors. Circulation 106:1962–1967

    Article  CAS  PubMed  Google Scholar 

  • Conway DS, Pearce LA, Chin BS, Hart RG, Lip GY (2003) Prognostic value of plasma von Willebrand factor and soluble P-selectin as indices of endothelial damage and platelet activation in 994 patients with nonvalvular atrial fibrillation. Circulation 107(25):3141–3145

    Article  CAS  PubMed  Google Scholar 

  • Corash L (1990) Measurement of platelet activation by fluorescence-activated flow cytometry. Blood Cells 16:97–106

    CAS  PubMed  Google Scholar 

  • De Boer AC, Han P, Turpie AG, Butt R, Zielinsky A, Genton E (1981) Plasma and urine beta thromboglobulin concentration in patients with deep vein thrombosis. Blood 58:693–698

    PubMed  Google Scholar 

  • Diener HC, Lowenthal A (1997) Antiplatelet therapy to prevent stroke: risk of brain hemorrhage and efficacy in atrial fibrillation. J Neurol Sci 153:112

    Article  Google Scholar 

  • EAFT (European Atrial Fibrillation Trial) Study Group (1993) Secondary prevention in non-rheumatic atrial fibrillation after transient ischaemic attack or minor stroke. Lancet 342:1255–1262

    Google Scholar 

  • Edvardsson N, Juul-Möller S, Omblus R, Pehrsson K (2003) Effects of low-dose warfarin and aspirin versus no treatment on stroke in a medium-risk patient population with atrial fibrillation. J Intern Med 254:95–101

    Article  CAS  PubMed  Google Scholar 

  • Farrell B, Godwin J, Richards S, Warlow C (1991) The United Kingdom transient ischemic attack aspirin trial. Final results. J Neurol Neurosurg Psychiatry 54:1044–1054

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Feinberg WM, Pearce LA, Hart RG, Cushman M, Cornell ES, Lip GY, Bovill EG (1999) Markers of thrombin and platelet activity in patients with atrial fibrillation: correlation with stroke among 1531 participants in the stroke prevention in atrial fibrillation III study. Stroke 30:2547–2553

    Article  CAS  PubMed  Google Scholar 

  • FFAACS (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontane) Investigators (2001) Anticoagulant (fluindione)-aspirin combination in patients with high-risk atrial fibrillation. A randomized trial (Fluindione, Fibrillation Auriculaire, Aspirin et Contraste Spontané; FFAACS). Cerebrovasc Dis 12:245–252

    Article  Google Scholar 

  • FitzGerald DJ, Catella F, Roy L, FitzGerald GA (1988) Marked platelet activation in vivo after intravenous streptokinase in patients with acute myocardial infarction. Circulation 77:142–150

    Article  CAS  PubMed  Google Scholar 

  • Freestone B, Chong AY, Nuttall S, Blann AD, Lip GY (2007) Soluble E-selectin, von Willebrand factor, soluble thrombomodulin, and total body nitrate/nitrite product as indices of endothelial damage/dysfunction in paroxysmal, persistent, and permanent atrial fibrillation. Chest 132:1253–1258

    Article  CAS  PubMed  Google Scholar 

  • Fu R, Wu S, Wu P, Qui J (2011) A Study of blood soluble P-selectin, fibrinogen, and von Willebrand factor levels in idiopathic and lone atrial fibrillation. Europace 13:31–36

    Article  PubMed  Google Scholar 

  • Furui H, Taniguchi N, Yamauchi K, Sotobata I, Saito H, Inagaki H (1987a) Effects of treadmill exercise on platelet function, blood coagulability and fibrinolytic activity in patients with atrial fibrillation. Jpn Heart J 28:177–184

    Article  CAS  PubMed  Google Scholar 

  • Furui H, Taniguchi N, Yamauchi K, Sotobata I, Saito H, Inagaki H (1987b) Effects of treadmill exercise on platelet function, blood coagulability and fibrinolytic activity in patients with atrial fibrillation. Jpn Heart J 28:177–184

    Article  CAS  PubMed  Google Scholar 

  • Gabassov VA, Popov EG, Gavrilov II, Ela P, Markosian RA (1989) New methodical approach to the study of platelet aggregation in vitro. Biull Eksp Biol Med 108:437–440

    CAS  PubMed  Google Scholar 

  • Goette A, Weber M, Lendeckel U, Welte T, Lutze G, Klein HU (2004) Effect of physical exercise on platelet activity and the von-Willebrand-factor in patients with persistent lone atrial fibrillation. J Interv Card Electrophysiol 10:139–146

    Article  PubMed  Google Scholar 

  • Goldsmith I, Kumar P, Carter P, Blann AD, Patel RL, Lip GYH (2000a) Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study. Am Heart J 140:777–784

    Article  CAS  PubMed  Google Scholar 

  • Goldsmith I, Li Saw Hee FL, Blann AD, Lip GYH (2000b) Increased platelet activation and endothelial dysfunction in patients immediately following percutaneous balloon mitral valvuloplasty. Clin Cardiol 23:587–590

    Article  CAS  PubMed  Google Scholar 

  • Goldsmith I, Blann AD, Patel RL, Lip GYH (2000c) Reduced indices of left atrial hypercoagulability in patients with severe mitral regurgitation. Am J Cardiol 86:234–236

    Article  CAS  PubMed  Google Scholar 

  • Goldsmith I, Kumar P, Carter P, Blann AD, Patel RL, Lip GYH (2000d) Atrial endocardial changes in mitral valve disease: a scanning electron microscopy study. Am Heart J 140:777–784

    Article  CAS  PubMed  Google Scholar 

  • Grau AJ, Ruf A, Vogt A, Lichy C, Buggle F, Patscheke H, Hacke W (1998) Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemia. Thromb Haemost 80:298–301

    CAS  PubMed  Google Scholar 

  • Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J (1990a) Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stroke 21:47–51

    Article  CAS  PubMed  Google Scholar 

  • Gustafsson C, Blomback M, Britton M, Hamsten A, Svensson J (1990b) Coagulation factors and the increased risk of stroke in nonvalvular atrial fibrillation. Stoke 21:47–51

    CAS  Google Scholar 

  • Habara S, Dote K, Kato M, Sasaki S, Goto K, Takemoto H, Hasegawa D, Matsuda O (2007) Prediction of left atrial appendage thrombi in non-valvular atrial fibrillation. Eur Heart J 28(18):2217–2222

    Article  CAS  PubMed  Google Scholar 

  • Hamberg M, Svensson J, Wakabayashi T, Samuelsson B (1974) Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation. Proc Natl Acad Sci U S A 71:345–349

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hamberg M, Svensson J, Samuelsson B (1975) Thromboxanes: a new group of biologically active compounds derived from prostaglandin endoperoxides. Proc Natl Acad Sci U S A 72:2994–2998

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hart RG, Pearce LA, Aguilar MI (2007) Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation. Ann Intern Med 146:857–867

    Article  PubMed  Google Scholar 

  • Healey JS, Hart RG, Pogue J, Pfeffer MA, Hohnloser SH, De Caterina R, Flaker G, Yusuf S, Connolly SJ (2008) Risks and benefits of oral anticoagulation compared with clopidogrel plus aspirin in patients with atrial fibrillation according to stroke risk: the atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events (ACTIVE-W). Stroke 39:1482–1486

    Article  CAS  PubMed  Google Scholar 

  • Hellemons BS, Langenberg M, Lodder J, Vermeer F, Schouten HJ, Lemmens T, van Ree JW, Knottnerus JA et al (1999) Primary prevention of arterial thromboembolism in non-rheumatic atrial fibrillation in primary care: randomised controlled trial comparing two intensities of coumarin with aspirin. BMJ 319:958–964

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Heppell RM, Berkin KE, McLenachan JM, Davies JA (1997) Haemostatic and haemodynamic abnormalities associated with left atrial thrombosis in non rheumatic atrial fibrillation. Heart 77:407–411

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hijazi Z, Oldgren J, Andersson U, Connolly SJ, Ezekowitz MD, Hohnloser SH, Reilly PA, Vinereanu D, Siegbahn A, Yusuf S, Wallentin L (2012) Cardiac biomarkers are associated with an increased risk of stroke and death in patients with atrial fibrillation: a randomized evaluation of long-term anticoagulation therapy (re-ly) substudy. Circulation 125:1605–1616

    Article  CAS  PubMed  Google Scholar 

  • Ikeda U, Yamamoto K, Shimada K (1997) Biochemical markers of coagulation activation in mitral stenosis, atrial fibrillation and cardiomyopathy. Clin Cardiol 20:7–10

    Article  CAS  PubMed  Google Scholar 

  • Kamath S, Chin BS, Blann AD, Lip GY (2002a) A study of platelet activation in paroxysmal, persistent and permanent atrial fibrillation. Blood Coagul Fibrinolysis 13:627–636

    Article  CAS  PubMed  Google Scholar 

  • Kamath S, Blann AD, Chin BSP, Lanza F, Aleil B, Cazenave JP, Lip GYH (2002b) A study of platelet activation in atrial fibrillation and the effects of antithrombotic therapy. Eur Heart J 23:1788–1795

    Article  CAS  PubMed  Google Scholar 

  • Kamath S, Blann AD, Chin BSP, Lip GYH (2003) Platelet activation, hemorheology and thrombogenesis in acute atrial fibrillation: a comparison with permanent atrial fibrillation. Heart 89:1093–1095

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Kataoka H, Yano S, Mikuriya Y (1994) Relationship of mitral valve area to hemostatic condition in rheumatic mitral stenosis. J Cardiol 24:387–395

    CAS  PubMed  Google Scholar 

  • Kawai Y, Handa M, Nagai H, Kamata T, Anbo H, Kawano K, Araki Y, Yamamoto M, Ikeda Y, Watanabe K (1989) Role of membrane glycoproteins in the interaction of blood platelets with the vessel wall – the study on platelet adhesion to in vitro cultured subendothelial matrix. Nippon Ketsueki Gakkai Zasshi 52:1312–1321

    CAS  PubMed  Google Scholar 

  • Koefoed BG, Feddersen C, Gullov AL, Petersen P (1997) Effect of fixed minidose warfarin, conventional dose warfarin and aspirin on INR and prothrombin fragment 1 + 2 in patients with atrial fibrillation. Thromb Haemost 77:845–848

    CAS  PubMed  Google Scholar 

  • Kranidis A, Koulouris S, Anthopoulos L (1993a) Clinical implications of left atrial spontaneous echo contrast in mitral valve disease. J Heart Valve Dis 2:267–272

    CAS  PubMed  Google Scholar 

  • Kranidis A, Koulouris S, Anthopoulos L (1993b) Clinical implications of left atrial spontaneous echo contrast in mitral valve disease. J Heart Valve Dis 2:267–272

    CAS  PubMed  Google Scholar 

  • Li Saw Hee FL, Blann AD, Goldmsith I, Lip GY (1999) Indexes of hypercoagulability measured in peripheral blood reflect levels in intracardiac blood in patients with atrial fibrillation secondary to mitral stenosis. Am J Cardiol 83:1206–1209

    Article  CAS  PubMed  Google Scholar 

  • Li Saw Hee FL, Blann AD, Lip GYH (2000) Fixed, low-dose warfarin, aspirin-warfarin combination therapy and dose-adjusted warfarin on thrombogenesis in chronic atrial fibrillation. Stroke 31:828–833

    Article  CAS  PubMed  Google Scholar 

  • Li Saw Hee FL, Blann AD, Gibbs CR, Edmunds E, Lip GYH (2001) Effect of exercise on haemostatic markers in patients with chronic atrial fibrillation. Clin Cardiol 24:409–414

    Article  CAS  PubMed  Google Scholar 

  • Lip GY (1995) Does atrial fibrillation confer a hypercoagulable state? Lancet 346:1313–1314

    Article  CAS  PubMed  Google Scholar 

  • Lip GY, Lowe GD, Rumley A, Dunn FG (1995) Increased markers of thrombogenesis in chronic atrial fibrillation: effects of warfarin treatment. Br Heart J 73:527–533

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Lip GY, Lip PL, Zarifis J, Watson RD, Bareford D, Lowe GD, Beevers DG (1996a) Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation 94:425–431

    Article  CAS  PubMed  Google Scholar 

  • Lip GYH, Lip PL, Zarifis J, Watson RD, Bareford D, Lowe GD, Beevers DG (1996b) Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin. Circulation 94:425–431

    Article  CAS  PubMed  Google Scholar 

  • Lip GY, Lane D, Van Walraven C, Hart RG (2006) Additive role of plasma von Willebrand factor levels to clinical factors for risk stratification of patients with atrial fibrillation. Stroke 37:2294–2300

    Article  CAS  PubMed  Google Scholar 

  • Lip GY, Patel JV, Hughes E, Hart RG (2007) High-sensitivity C-reactive protein and soluble CD40 ligand as indices of inflammation and platelet activation in 880 patients with nonvalvular atrial fibrillation: relationship to stroke risk factors, stroke risk stratification schema, and prognosis. Stroke 38:1229–1237

    Article  CAS  PubMed  Google Scholar 

  • Lip GY, Rasmussen LH, Olsson SB, Jensen EC, Persson AL, Eriksson U, Wåhlander KF, Committee S (2009) Oral direct thrombin inhibitor AZD0837 for the prevention of stroke and systemic embolism in patients with non-valvular atrial fibrillation: a randomized dose-guiding, safety, and tolerability study of four doses of AZD0837 vs. vitamin K antagonists. Eur Heart J 30(23):2897–2907

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Li-Saw-Hee FL, Blann AD, Gurney D, Lip GY (2001a) Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. Eur Heart J 22:1741–1747

    Article  CAS  PubMed  Google Scholar 

  • Li-Saw-Hee FL, Blann AD, Gurney D, Lip GY (2001b) Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Effects of cardioversion and return of left atrial function. Eur Heart J 22:1741–1747

    Article  CAS  PubMed  Google Scholar 

  • Maly J, Pecka M, Vodckova L, Pidrman V, Malá H, Bláha M, Jebavý L (1990) Changes in the activity of thrombocytes by smoking. Sb Ved Pr Lek Fak Karlovy Univ Hradci Kralove 33:325–333

    CAS  Google Scholar 

  • Mant J, Hobbs FD, Fletcher K, Roalfe A, Fitzmaurice D, Lip GY, Murray E, BAFTA investigators, Midland Research Practices Network (MidReC) (2001) Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial. Lancet 370:493–503

    Article  CAS  Google Scholar 

  • Minamino T, Kitakaze M, Sato H, Asanuma H, Funaya H, Koretsune Y, Hori M (1997) Plasma levels of nitrite/nitrate and platelet C-GMP levels are decreased in patients with atrial fibrillation. Arterioscler Thromb Vasc Biol 17:3191–3195

    Article  CAS  PubMed  Google Scholar 

  • Minamino T, Kitakaze M, Sanada S, Asanuama H, Kurotobi T, Koretsune Y, Fukunami M, Kuzuya T, Hoki N, Hori M (1998) Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide. Circulation 98:1721–1727

    Article  CAS  PubMed  Google Scholar 

  • Minamino T, Kitakaze M, Sato H, Asanuma H, Ueda Y, Koretsune Y, Kuzuya T, Hori M (1999) Plasma adenosine levels and platelet activation in patients with atrial fibrillation. Am J Cardiol 83:194–198

    Article  CAS  PubMed  Google Scholar 

  • Morocutti C, Amabile G, Fattapposta F, Nicolosi A, Matteoli S, Trappolini M, Cataldo G, Milanesi G, Lavezzari M, Pamparana F, Coccheri S (1997) Indobufen versus warfarin in the secondary prevention of major vascular events in nonrheumatic atrial fibrillation. SIFA (Studio Italiano Fibrillazione Atriale) Investigators. Stroke 28:1015–1012

    Article  CAS  PubMed  Google Scholar 

  • Müller I, Massberg S, Zierhut W, Binz C, Schuster A, Rüdiger-von Hoch S, Braun S, Gawaz M (2002) Effects of aspirin and clopidogrel versus oral anticoagulation on platelet function and on coagulation in patients with nonvalvular atrial fibrillation (CLAFIB). Pathophysiol Haemost Thromb 32:16–24

    Article  PubMed  Google Scholar 

  • Mustard JF, Packham MA (1975) The role of blood and platelets in atherosclerosis and the complications of atherosclerosis. Thromb Diath Haemorrh 33:444–456

    CAS  PubMed  Google Scholar 

  • Mustard JF, Packham MA, Rowsell HX, Jorgensen L (1968) The role of thrombogenic factors in atherosclerosis. Ann NY Acad Sci 149:848–859

    Article  CAS  PubMed  Google Scholar 

  • Nakagami H, Yamamoto K, Ikeda U, Mitsuhashi T, Goto T, Shimada K (1998) Mitral regurgitation reduces the risk of stroke in patients with nonrheumatic atrial fibrillation. Am Heart J 136:528–532

    Article  CAS  PubMed  Google Scholar 

  • Nikitovic D, Zacharis EA, Manios EG, Malliaraki NE, Kanoupakis EM, Sfiridaki KI, Skalidis EI, Margioris AN, Vardas PE (2002) Plasma levels of nitrites/nitrates in patients with chronic atrial fibrillation are increased after electrical restoration of sinus rhythm. J Interv Card Electrophysiol 7:171–176

    Article  PubMed  Google Scholar 

  • Nurden AT, Bihour C, Macchi L, Lacaze D, Durrieu C, Besse P, Dachary J, Hourdillé P (1993) Platelet activation in thrombotic disorders. Nouv Rev Fr Hematol 35:67–71

    CAS  PubMed  Google Scholar 

  • Ohara K, Inoue H, Nozawa T, Hirai T, Iwasa A, Okumura K, Lee JD, Shimizu A, Hayano M, Yano K (2007) Accumulation of risk factors enhances the prothrombotic state in atrial fibrillation. Int J Cardiol 126:316–321

    Article  PubMed  Google Scholar 

  • Pérez-Gómez F, Alegría E, Berjón J, Iriarte JA, Zumalde J, Salvador A, Mataix L, Investigators NASPEAF (2004) Comparative effects of antiplatelet, anticoagulant, or combined therapy in patients with valvular and nonvalvular atrial fibrillation: a randomized multicenter study. J Am Coll Cardiol 44:1557–1566

    Article  PubMed  CAS  Google Scholar 

  • Petersen P, Boysen G (1990) Prevention of stroke in atrial fibrillation. N Engl J Med 323:482

    Google Scholar 

  • Petersen P, Boysen G, Godtfredsen J, Andersen ED, Andersen B (1989) Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The copenhagen AFASAK study. Lancet 1:175–179

    Article  CAS  PubMed  Google Scholar 

  • Peverill RE, Harper RW, Gelman J, Gan TE, Harris G, Smolich JJ (1996) Determinants of increased regional left atrial coagulation activity in patients with mitral stenosis. Circulation 94:331–339

    Article  CAS  PubMed  Google Scholar 

  • Pongratz G, Brandt-Pohlmann M, Henncke KH, Pohle C, Zink D, Gehling G, Bachmann K (1997) Platelet activation in embolic and preembolic status of patients with non rheumatic atrial fibrillation. Chest 111:929–933

    Article  CAS  PubMed  Google Scholar 

  • Posada IS, Barriales V (1999) Alternate-day dosing of aspirin in atrial fibrillation. LASAF Pilot Study Group. Am Heart J 138:137–143

    Article  CAS  PubMed  Google Scholar 

  • Rash A, Downes T, Portner R, Yeo WW, Morgan N, Channer KS (2007) A randomised controlled trial of warfarin versus aspirin for stroke prevention in octogenarians with atrial fibrillation (WASPO). Age Ageing 36:151–156

    Article  PubMed  Google Scholar 

  • Reinders JH, de Groot PG, Sixma JJ, Van Mourik JA (1988) Storage and secretion of von Willebrand factor by endothelial cells. Haemostasis 18:246–261

    CAS  PubMed  Google Scholar 

  • Sato H, Ishikawa K, Kitabatake A, Ogawa S, Maruyama Y, Yokota Y, Fukuyama T, Doi Y, Mochizuki S, Izumi T, Takekoshi N, Yoshida K, Hiramori K, Origasa H, Uchiyama S, Matsumoto M, Yamaguchi T, Hori M, Japan Atrial Fibrillation Stroke Trial Group (2006) Low-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke Trial. Stroke 37:447–451

    Article  CAS  PubMed  Google Scholar 

  • Seiss W (1989) Molecular mechanisms of platelet activation. Physiol Rev 69:58–178

    Google Scholar 

  • Sevush S, Jy W, Horstman LL, Mao WW, Kolodyn L, Ahn YS (1998) Platelet activation in Alzheimer disease. Arch Neurol 55:530–536

    Article  CAS  PubMed  Google Scholar 

  • Shinohara H, Fukuda N, Socki T, Takeichi N, Yui Y, Tamura Y, Oki T (1998) Relationship between flow dynamics in the left atrium and hemostatic abnormalities in patients with nonvalvular atrial fibrillation. Jpn Heart J 39:721–730

    Article  CAS  PubMed  Google Scholar 

  • Singer DE, Chang Y, Fang MC, Borowsky LH, Pomernacki NK, Udaltsova N, Go AS (2009) The net clinical benefit of warfarin anticoagulation in atrial fibrillation. Ann Intern Med 151:297–305

    Article  PubMed  PubMed Central  Google Scholar 

  • Sivenius J, Cunha L, Diener HC, Forbes C, Laakso M, Lowenthal A, Smets P, Riekkinen P Sr (1999) Second European Stroke Prevention Study: antiplatelet therapy is effective regardless of age. ESPS2 working group. Acta Neurol Scand 99:54–60

    Article  CAS  PubMed  Google Scholar 

  • Sixma JJ, Hindriks G, Van Breugel H, Hantgan R, de Groot PG (1991) Vessel wall proteins adhesive for platelets. J Biomater Sci Polym E 3:17–26

    Article  CAS  Google Scholar 

  • Sohara H, Amitani S, Kurose M, Miyahara K (1997) Atrial fibrillation activates platelets and coagulation in a time dependent manner: a study in patients with paroxysmal atrial fibrillation. J Am Coll Cardiol 29:106–112

    Article  CAS  PubMed  Google Scholar 

  • Stroke prevention in atrial fibrillation (SPAF) investigators (1993) A differential effect of aspirin in prevention of stroke in atrial fibrillation. J Stroke Cerebrovasc Dis 3:181–188

    Google Scholar 

  • Stroke Prevention in Atrial Fibrillation Investigators (1994) Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study. Lancet 343:687–691

    Google Scholar 

  • Stroke Prevention in Atrial Fibrillation Investigators (1996) Adjusted-dose warfarin versus low-intensity, fixed-dose warfarin plus aspirin for high-risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomised clinical trial. Lancet 348:633–638

    Article  Google Scholar 

  • Stroke Prevention in Atrial Fibrillation Study (1991) Final results. Circulation 84:527–539

    Article  Google Scholar 

  • Tayebjee MH, Lip GY (2003) Fibrin D-dimer levels in atrial fibrillation as an index of thrombogenesis: a possible test to exclude left atrial thrombus? Am J Cardiol 92:47–49

    Article  CAS  PubMed  Google Scholar 

  • Topaloglu S, Boyaci A, Ayaz S, Yilmaz S, Yanik O, Ozdemir O, Soylu M, Demir AD, Aras D, Kisacik HL, Korkmaz S (2007) Coagulation, fibrinolytic system activation and endothelial dysfunction in patients with mitral stenosis and sinus rhythm. Angiology 58:85–91

    Article  PubMed  Google Scholar 

  • Tschoepe D, Roesen P, Esser J, Schwippert B, Nieuwenhuis HK, Kehrel B, Gries FA (1991) Large platelets circulate in an activated state in diabetes mellitus. Semin Thromb Hemost 17:433–438

    Article  CAS  PubMed  Google Scholar 

  • Vemmos KN, Tsivgoulis G, Spengos K, Manios E, Xinos K, Vassilopoulou S, Zakopoulos N, Moulopoulos S (2006) Primary prevention of arterial thromboembolism in the oldest old with atrial fibrillation – a randomized pilot trial comparing adjusted-dose and fixed low-dose coumadin with aspirin. Eur J Intern Med 1:48–52

    Article  CAS  Google Scholar 

  • Watson T, Shantsila E, Lip GY (2009) Mechanisms of thrombogenesis in atrial fibrillation: Virchow’s triad revisited. Lancet 373:155–166

    Article  CAS  PubMed  Google Scholar 

  • Weitz JI, Connolly SJ, Patel I, Salazar D, Rohatagi S, Mendell J, Kastrissios H, Jin J, Kunitada S (2010) Randomised, parallel-group, multicentre, multinational phase 2 study comparing edoxaban, an oral factor Xa inhibitor, with warfarin for stroke prevention in patients with atrial fibrillation. Thromb Haemost 104(3):633–641

    Article  CAS  PubMed  Google Scholar 

  • Wipf JE, Lipsky BA (1990) Atrial fibrillation. Thromboembolic risk and indications for anticoagulation. Arch Intern Med 150:1598–1603

    Article  CAS  PubMed  Google Scholar 

  • Wysokinski WE, Owen WG, Fass DN, Patrzalek DD, Murphy L, McBane RD 2nd (2004) Atrial fibrillation and thrombosis: immunohistochemical differences between in situ and embolized thrombi. J Thromb Haemost 2:1637–1644

    Article  CAS  PubMed  Google Scholar 

  • Yamamoto K, Ikeda U, Seimo Y, Mito H, Fujikawa H, Sekiguchi H, Shimada K (1995) Coagulation activity is increased in the left atrium of patients with Mitral Stenosis. J Am Coll Cardiol 25:107–112

    Article  CAS  PubMed  Google Scholar 

  • Yamauchi K, Furui H, Taniguchi N, Sotobata I (1986a) Plasma beta-thromboglobulin and platelet factor 4 concentrations in patients with atrial fibrillation. Jpn Heart J 27:481–487

    Article  CAS  PubMed  Google Scholar 

  • Yamauchi K, Furui H, Taniguchi N, Sotobata I (1986b) Plasma beta-thromboglobulin and platelet factor 4 concentrations in patients with atrial fibrillation. Jpn Heart J 27:481–487

    Article  CAS  PubMed  Google Scholar 

  • Yip HK, Chang LT, Sun CK, Yang CH, Hung WC, Hang CL, Wu CJ, Chua S, Yeh KH, Chang HW (2006) Platelet activation in patients with chronic nonvalvular atrial fibrillation. Int Heart J 47:371–379

    Article  CAS  PubMed  Google Scholar 

  • Yip HK, Lai SL, Lan MY, Chang WN, Liu JS, Kao YF, Chang YY, Lu CH, Chen WH, Lin HH, Liou CW (2007) Time course of platelet activation and von Willebrand factor in patients with non-valvular atrial fibrillation after ischemic stroke. Circ J 71:321–326

    Article  CAS  PubMed  Google Scholar 

  • Yuce M, Cakici M, Davutoglu V, Ozer O, Sari I, Ercan S, Sucu M, Dogan A, Yavuz F (2010) Relationship between mean platelet volume and atrial thrombus in patients with atrial fibrillation. Blood Coagul Fibrinolysis 21:722–725

    PubMed  Google Scholar 

Further Reading

  • van Walraven C, Hart RG, Singer DE, Laupacis A, Connolly S, Petersen P, Koudstaal PJ, Chang Y, Hellemons B (2002) Oral anticoagulants vs aspirin in nonvalvular atrial fibrillation: an individual patient meta-analysis. JAMA 288:2441–2448

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. University of Birmingham Centre for Cardiovascular Sciences, City Hospital, Birmingham, B18 7QH, UK

    Gregory Y. H. Lip & Selvakumar Velu

Authors
  1. Gregory Y. H. Lip
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Selvakumar Velu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Gregory Y. H. Lip .

Editor information

Editors and Affiliations

  1. Division of Cardiovascular Disease Department of Internal Medicine, Health Care Center Bitterfeld, Bitterfeld-Wolfen, Germany

    Peter Lanzer

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer-Verlag Berlin Heidelberg

About this entry

Cite this entry

Lip, G.Y.H., Velu, S. (2015). Haemostasis and Thrombosis: Observations on Atrial Fibrillation and Platelets. In: Lanzer, P. (eds) PanVascular Medicine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-37078-6_236

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-37078-6_236

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-37077-9

  • Online ISBN: 978-3-642-37078-6

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation